Ageless Rx Review

Overview

Ageless Rx is a longevity and health optimization telehealth platform offering one of the broadest treatment menus in the direct-to-consumer space. Founded in 2020 and based in Phoenix, the company targets health-conscious adults interested in not just treating disease but in extending healthspan — the years spent in good metabolic and cognitive health.

The platform goes well beyond GLP-1 medications. Its catalog includes metformin (for both its established diabetes indication and its emerging longevity interest), NAD+ precursors, peptides, growth hormone secretagogues, and hormone replacement therapy. For patients who want a single provider coordinating a multi-pronged longevity protocol, Ageless Rx offers a scope that most telehealth platforms don't.

As of April 2026, the regulatory environment for compounded medications has tightened considerably. The FDA's semaglutide shortage exemption ended in February 2025, affecting the legal basis for compounding that formulation. Compounded tirzepatide faces additional enforcement action expected by April 2026. Patients considering GLP-1 options through Ageless Rx should verify current formulations and their regulatory status at agelessrx.com before enrolling.

The breadth of Ageless Rx's menu also means patients need to distinguish between treatments with well-established clinical evidence and those where the science is still developing — a distinction this profile addresses directly.

Medications Offered

• Compounded semaglutide (verify current availability — FDA shortage exemption ended February 2025)
• Compounded tirzepatide (verify current availability — 503B enforcement expected April 2026)
• Metformin — an FDA-approved medication with a well-established safety record; off-label longevity use is a legitimate area of ongoing clinical interest (see TAME trial)
• NAD+ precursors (NMN, NR) — see regulatory note below
• Peptide protocols — see regulatory note below
• Growth hormone secretagogues (e.g., sermorelin, ipamorelin) — verify current availability and prescribing status at agelessrx.com
• Hormone replacement therapy (HRT) — verify current protocols and formulations

Important note on peptides and NAD+: Several treatments on the Ageless Rx menu — including peptides such as BPC-157 and TB-500, and some NAD+ delivery formats — are not FDA-approved drugs. These compounds exist in a different regulatory category from FDA-approved medications like metformin or branded GLP-1s. Some may be dispensed through 503A/503B compounding pharmacies, but that dispensing pathway does not grant them the same clinical validation as FDA-approved treatments. Their safety and efficacy data is largely preclinical or from small, early-stage studies. Patients should understand this distinction before pursuing these protocols.

Pricing

All pricing estimates are April 2026 approximations. Verify current costs at agelessrx.com before enrolling, as compounding regulatory changes may have affected pricing and availability.

States Served

Ageless Rx serves patients across most U.S. states. Availability may vary by treatment type. Controlled substances and certain compounded medications have additional state-level prescribing restrictions. Verify in-state availability during the intake process at agelessrx.com.

Insurance

Ageless Rx operates primarily as a cash-pay platform. Most longevity and optimization-focused treatments are not covered by insurance. Metformin may be covered under standard prescription benefits for on-label use; off-label longevity use is typically not covered. Verify current insurance acceptance at agelessrx.com.

Consultation Process

1. Browse available protocols on the Ageless Rx website and select treatments of interest.
2. Complete an online intake form covering medical history, current medications, lab history, and treatment goals.
3. A licensed physician reviews your intake asynchronously and assesses eligibility.
4. If appropriate, prescriptions are issued and routed to a partner pharmacy for fulfillment.
5. Medications are shipped directly to your address with dosing instructions.
6. Ongoing monitoring and follow-up are conducted through the platform; some protocols may require periodic lab work.

Pros

• Broadest longevity treatment menu — few platforms match Ageless Rx's range of protocols, from metformin to GLP-1s to NAD+ to peptides.
• Metformin availability with clinical grounding — metformin has a strong safety record and genuine scientific interest in its longevity applications (TAME trial, epidemiological data); having it available alongside GLP-1s is genuinely useful for certain patients.
• GLP-1 + metabolic combo protocols — patients can explore combining metformin with GLP-1 therapy for metabolic management, a combination that has clinical precedent.
• Self-directed care model — the platform suits health-engaged patients who have done their research and want to customize a protocol.

Cons

• Wide variance in evidence quality — the menu spans FDA-approved drugs with decades of safety data (metformin) to research-category compounds with limited human trials (most peptides). Patients must do meaningful due diligence.
• Peptides and NAD+ are not FDA-approved treatments — including them in a clinical menu can create a false equivalence with approved drugs. Patients need to understand what they are and are not getting.
• GLP-1 compounding regulatory uncertainty — semaglutide shortage exemption ended February 2025; tirzepatide enforcement approaching April 2026. The formulary landscape is unsettled.
• Complexity requires patient sophistication — the platform works best for patients with a baseline understanding of these treatments; it is not designed for those looking for simple, guided weight loss support.
• Limited ongoing clinical oversight — the async model and broad catalog means the depth of monitoring per treatment may be less than a specialist-focused platform provides.

Best For

Health-engaged adults — men and women — who are interested in a multi-protocol longevity approach, understand the difference between FDA-approved and research-category treatments, and want a single platform where they can coordinate GLP-1 therapy, metformin, and other interventions. Not the right fit for patients seeking a simple, guided weight loss program.

Editorial Verdict

Ageless Rx occupies a genuinely distinct niche: a longevity-focused telehealth platform with more treatment breadth than almost any competitor. That breadth is also its main liability. Metformin and GLP-1s are well-validated; the longevity interest in metformin specifically is backed by serious clinical research, and having both available in one place is useful. But the peptide protocols and some NAD+ offerings occupy a very different regulatory and evidentiary category — and the platform does not always make that distinction obvious. Patients who approach Ageless Rx with clear-eyed expectations about what each treatment category represents will get real value from it. Those who don't may end up paying for treatments whose risk-benefit profile is much less established than the platform's clinical framing implies. Verify all current GLP-1 formulations and pricing given the compounding regulatory environment as of early 2026.

Related Content

• How Much Does Semaglutide Cost?
• How Much Does Tirzepatide Cost?
• Who Qualifies for GLP-1 Medications?